Edward J. Sitar
2020 - 9 METERS BIOPHARMA
In 2020, Edward J. Sitar earned a total compensation of $779.2K as Chief Financial Officer at 9 METERS BIOPHARMA, a 27% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $86,400 |
|---|---|
| Option Awards | $381,810 |
| Salary | $311,000 |
| Total | $779,210 |
Sitar received $381.8K in option awards, accounting for 49% of the total pay in 2020.
Sitar also received $86.4K in non-equity incentive plan and $311K in salary.
Rankings
In 2020, Edward J. Sitar's compensation ranked 9,591st out of 13,090 executives tracked by ExecPay. In other words, Sitar earned more than 26.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,591 out of 13,090 | 27th |
Division Manufacturing | 4,114 out of 5,621 | 27th |
Major group Chemicals And Allied Products | 1,681 out of 2,254 | 25th |
Industry group Drugs | 1,473 out of 1,954 | 25th |
Industry Pharmaceutical Preparations | 1,085 out of 1,459 | 26th |
Source: SEC filing on May 12, 2021.
Sitar's colleagues
We found three more compensation records of executives who worked with Edward J. Sitar at 9 METERS BIOPHARMA in 2020.